Home
Products
Reagents for Polymerization
Polymerization Catalysts
Cross-Coupling Reaction Catalyst
Pyrido[2,3-b]pyrazin-7-ylboronic acid, pinacol ester

Pyrido[2,3-b]pyrazin-7-ylboronic acid, pinacol ester

Name: Pyrido[2,3-b]pyrazin-7-ylboronic acid, pinacol ester
Brand: BOC Sciences
Rating: 5 (1 reviews)

Inquiry

Molecular Formula:

C13H16BN3O2

Molecular Weight:

257.1

CAS Number:

1210047-44-1

Catalog Number:

1210047-44-1

Product Information

Molecular Formula:

C13H16BN3O2

Molecular Weight:

257.1

Description

Pyrido[2,3-b]pyrazin-7-ylboronic acid, pinacol ester is an indispensable compound in the realm of the biomedical sector. Its utilization revolves around the exploration of revolutionary pharmaceutical solutions, transcending the boundaries of maladies comprising cancer, diabetes, and neurodegenerative conditions. Notably, this ester derivative presents a remarkable amplitude of improved reliability, solubility, and bioavailability, serving as a promising adjunct in forging proficient drug formulation and dispensation mechanisms.

Synonyms

7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrido[2,3-b]pyrazine; 1210047-44-1; Pyrido[2,3-b]pyrazin-7-ylboronicacidpinacolester; 7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDO[2,3-B]PYRAZINE; Pyrido[2,3-b]pyrazine-7-boronicacid,pinacolester; Pyrido[2,3-b]pyrazin-7-ylboronicacid,pinacolester

IUPAC Name

7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrido[2,3-b]pyrazine

Canonical SMILES

B1(OC(C(O1)(C)C)(C)C)C2=CC3=NC=CN=C3N=C2

InChI

InChI=1S/C13H16BN3O2/c1-12(2)13(3,4)19-14(18-12)9-7-10-11(17-8-9)16-6-5-15-10/h5-8H,1-4H3

InChI Key

QLYMAIYXJXENHJ-UHFFFAOYSA-N

Melting Point

167-172 °C

Flash Point

Not applicable

Purity

95%

Storage

2-8°C

Safety Information

Hazards

H315 - H319 - H335

Precautionary Statement

P302 + P352 - P305 + P351 + P338

Computed Properties

Hydrogen Bond Donor Count

Hydrogen Bond Acceptor Count

Rotatable Bond Count

Exact Mass

257.1335569 g/mol

Monoisotopic Mass

257.1335569 g/mol

Topological Polar Surface Area

57.1Å²

Heavy Atom Count

Formal Charge

Complexity

335

Isotope Atom Count

Defined Atom Stereocenter Count

Undefined Atom Stereocenter Count

Defined Bond Stereocenter Count

Undefined Bond Stereocenter Count

Covalently-Bonded Unit Count

Compound Is Canonicalized

Yes

Patents

Publication Number	Title	Priority Date
WO-2021249913-A9	2'-(quinolin-3-yl)-5',6'-dihydrospiro[azetidine-3,4'-pyrrolo[1,2-b]pyrazole]-1-carboxylate derivatives and related compounds as map4k1 (hpk1) inhibitors for the treatment of cancer	2020-06-09
US-2021078975-A1	Fused cyclic urea derivatives as crhr2 antagonist	2018-04-09
US-10266532-B2	Tricyclic modulators of TNF signaling	2015-04-17
US-2016304517-A1	Tricyclic modulators of tnf signaling	2015-04-17
US-2018179198-A1	Tricyclic modulators of tnf signaling	2015-04-17
US-9856253-B2	Tricyclic modulators of TNF signaling	2015-04-17
US-2014179676-A1	Heterocyclic nuclear hormone receptor modulators	2012-12-21
US-9150592-B2	Heterocyclic nuclear hormone receptor modulators	2012-12-21
US-2014045814-A1	Pyrazine derivatives as fgfr inhibitors	2012-08-10
US-2016280713-A1	Pyrazine derivatives as fgfr inhibitors	2012-08-10